These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6276295)
1. Cyclosporin A abrogates proliferation of T cells and generation of suppressor and cytotoxic T-cell function induced by Epstein-Barr virus. Palacios R Immunobiology; 1981; 160(3-4):321-9. PubMed ID: 6276295 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture. Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus increases the proliferative response and the generation of suppressor and cytotoxic T-cell functions in autologous mixed lymphocyte reaction. Palacios R Scand J Immunol; 1982 Jan; 15(1):17-24. PubMed ID: 6280268 [TBL] [Abstract][Full Text] [Related]
4. Cyclosporin abrogates virus-specific T-cell control of EBV-induced B-cell lymphoproliferation. York LJ; Qualtiere LF Viral Immunol; 1990; 3(2):127-36. PubMed ID: 2163257 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells. Konttinen YT; Bluestein HG; Zvaifler NJ J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells. Harada S; Katsuki T; Yamamoto H; Hinuma Y Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019 [TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cells. Bejarano MT; Masucci MG; Ernberg I; Klein E; Klein G Int J Cancer; 1985 Mar; 35(3):327-33. PubMed ID: 2982748 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Bird AG; McLachlan SM; Britton S Nature; 1981 Jan; 289(5795):300-1. PubMed ID: 6256660 [TBL] [Abstract][Full Text] [Related]
9. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263 [TBL] [Abstract][Full Text] [Related]
10. T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Rickinson AB; Rowe M; Hart IJ; Yao QY; Henderson LE; Rabin H; Epstein MA Cell Immunol; 1984 Sep; 87(2):646-58. PubMed ID: 6088089 [TBL] [Abstract][Full Text] [Related]
11. Generation of Epstein-Barr virus antigen-specific suppressor T cells in vitro. Sundar SK; Menezes J Int J Cancer; 1985 Mar; 35(3):351-7. PubMed ID: 2579037 [TBL] [Abstract][Full Text] [Related]
12. Effect of cyclosporin and interleukin-2 on the restoration of in vitro immune responses to cytomegalovirus. Converse PJ; Hess AD Scand J Immunol; 1985 Feb; 21(2):109-18. PubMed ID: 2983414 [TBL] [Abstract][Full Text] [Related]
13. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line. Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663 [TBL] [Abstract][Full Text] [Related]
14. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. Tosato G; Magrath IT; Blaese RM J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2. Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919 [TBL] [Abstract][Full Text] [Related]
17. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis. Wang F; Blaese RM; Zoon KC; Tosato G J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis. McChesney MB; Bankhurst AD Ann Rheum Dis; 1986 Jul; 45(7):546-52. PubMed ID: 3017244 [TBL] [Abstract][Full Text] [Related]
20. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component. Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]